Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

44 structures for P00338

Entry ID Method Resolution Chain Position Source
1I10 X-ray 230 A A/B/C/D/E/F/G/H 2-332 PDB
4AJP X-ray 238 A A/B/C/D 2-332 PDB
4JNK X-ray 190 A A/B/C/D 2-332 PDB
4L4R X-ray 210 A A/H 2-332 PDB
4L4S X-ray 290 A A/H 2-332 PDB
4M49 X-ray 205 A A/B/C/D 2-332 PDB
4OJN X-ray 240 A A/B/C/D/E/F/G/H 2-332 PDB
4OKN X-ray 210 A A/B/C/D/E/F/G/H 2-332 PDB
4QO7 X-ray 214 A A/B/C/D 2-332 PDB
4QO8 X-ray 200 A A/B/C/D 2-332 PDB
4QSM X-ray 300 A A/B/C/D/E/F/G/H 2-332 PDB
4QT0 X-ray 320 A A/B/C/D/E/F/G/H 2-332 PDB
4R68 X-ray 211 A A/B/C/D 2-332 PDB
4R69 X-ray 319 A A/B/C/D 2-332 PDB
4RLS X-ray 191 A A/B/C/D 2-332 PDB
4ZVV X-ray 220 A A/B/C/D 1-332 PDB
5IXS X-ray 205 A A/B/C/D 2-332 PDB
5IXY X-ray 300 A A/B/C/D 2-332 PDB
5W8H X-ray 180 A A/B/C/D 1-332 PDB
5W8I X-ray 195 A A/B/C/D 1-332 PDB
5W8J X-ray 155 A A/B/C/D 1-332 PDB
5W8K X-ray 160 A A/B/C/D 1-332 PDB
5W8L X-ray 195 A A/B/C/D 1-332 PDB
5ZJD X-ray 239 A A/B/C/D/E/F/G/H 2-332 PDB
5ZJE X-ray 293 A A/B/C/D/E/F/G/H/I/J/K/L 2-332 PDB
5ZJF X-ray 260 A A/B/C/D/E/F/G/H/I/J/K/L 2-332 PDB
6BAD X-ray 210 A A/B/C/D 2-332 PDB
6BAG X-ray 240 A A/B/C/D 2-332 PDB
6BAX X-ray 205 A A/B/C/D 2-332 PDB
6BAZ X-ray 270 A A/B/C/D 2-332 PDB
6BB0 X-ray 195 A A/B/C/D 2-332 PDB
6BB1 X-ray 230 A A/B/C/D/E/F/G/H 2-332 PDB
6BB2 X-ray 247 A A/B/C/D/E/F/G/H 2-332 PDB
6BB3 X-ray 240 A A/B/C/D 2-332 PDB
6MV8 X-ray 195 A A/B/C/D 1-332 PDB
6MVA X-ray 202 A A/B/C/D 1-332 PDB
6Q0D X-ray 205 A A/B/C/D/E/F 1-332 PDB
6Q13 X-ray 200 A A/B/C/D 1-332 PDB
6SBU X-ray 291 A A/B/C/D/E/F/G/H 2-332 PDB
6SBV X-ray 260 A A/B/C/D/E/F/G/H 2-332 PDB
6ZZR X-ray 265 A AAA/BBB/CCC/DDD/EEE/FFF/GGG/HHH 2-332 PDB
7M2N X-ray 250 A A/B/C/D 1-332 PDB
8FW6 X-ray 234 A A/B 1-332 PDB
AF-P00338-F1 Predicted AlphaFoldDB

239 variants for P00338

Variant ID(s) Position Change Description Diseaes Association Provenance
rs200251957
RCV001586145
CA5911162
RCV001351584
3 T>I Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA379500812
rs1264619847
RCV001107008
16 E>G Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
COSM257282
rs144856598
RCV001351844
CA5911210
55 E>K Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency Variant assessed as Somatic; 0.0 impact. large_intestine [ClinVar, NCI-TCGA, Cosmic] Yes ClinGen
cosmic curated
ClinVar
ESP
ExAC
NCI-TCGA
dbSNP
gnomAD
CA5911204
RCV001107009
rs201460924
75 P>V Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA5911278
rs184074326
RCV001107662
136 V>I Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
RCV001329431
rs768761936
159 I>N Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency [ClinVar] Yes ClinVar
dbSNP
RCV001107663
CA5911303
RCV000675421
rs116841148
176 E>S Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA5911346
RCV000423489
RCV001104040
RCV000675426
rs34305721
203 G>A Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001104039
rs200586792
CA5911320
209 V>F Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
RCV000779053
rs751851558
225 E>missing Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency [ClinVar] Yes ClinVar
dbSNP
CA5911357
RCV000556498
rs141158742
232 K>N Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs779893062
RCV001207792
255 S>missing Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency [ClinVar] Yes ClinVar
dbSNP
RCV001303380
CA5911441
COSM925636
rs140090654
315 R>H Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency Variant assessed as Somatic; 0.0 impact. endometrium [ClinVar, NCI-TCGA, Cosmic] Yes ClinGen
cosmic curated
ClinVar
ESP
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
CA124123
rs121912479
RCV000015668
329 E>* Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
TCGA novel 2 A>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA218581673
rs375339263
3 T>A No ClinGen
ESP
gnomAD
CA379499895
rs1452907923
5 K>* No ClinGen
TOPMed
CA5911163
rs771136276
5 K>R No ClinGen
ExAC
gnomAD
rs978565281
CA218581490
6 D>E No ClinGen
TOPMed
rs1049174299
CA218581497
9 I>P No ClinGen
TOPMed
gnomAD
rs769816031
CA5911142
10 Y>* No ClinGen
ExAC
TOPMed
gnomAD
CA674330550
rs1359100834
10 Y>* No ClinGen
TOPMed
rs746791147
CA5911165
10 Y>C No ClinGen
ExAC
TOPMed
gnomAD
rs1172408087
CA379500075
11 N>A No ClinGen
gnomAD
rs559240574
CA218581498
13 L>K No ClinGen
1000Genomes
CA218581499
rs559240574
13 L>R No ClinGen
1000Genomes
rs776461335
CA5911167
13 L>V No ClinGen
ExAC
gnomAD
CA218581704
rs11553866
16 E>K No ClinGen
Ensembl
CA5911143
rs773454769
17 Q>F No ClinGen
ExAC
CA5911169
rs199585928
18 T>A No ClinGen
ExAC
TOPMed
CA5911172
rs537487381
18 T>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs186843316
CA5911144
18 T>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 18 T>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5911171
rs537487381
18 T>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs772645002
CA218581749
19 P>S No ClinGen
TOPMed
gnomAD
rs1287241973
CA379500303
19 P>Y No ClinGen
gnomAD
rs551357743
CA5911145
20 Q>G No ClinGen
1000Genomes
ExAC
gnomAD
rs373130532
CA5911161
22 K>M No ClinGen
ESP
ExAC
gnomAD
rs1167439642
CA379500506
23 I>A No ClinGen
gnomAD
rs759849879
CA5911175
23 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA379500928
rs1373704514
24 T>A No ClinGen
gnomAD
CA218581669
rs201366589
25 V>D No ClinGen
Ensembl
CA379500556
rs1393080737
26 V>F No ClinGen
gnomAD
rs1334676367
CA379500572
27 G>N No ClinGen
TOPMed
gnomAD
rs11553874
CA218581756
27 G>R No ClinGen
Ensembl
rs1332947241
CA379500966
27 G>V No ClinGen
TOPMed
CA379500590
rs1381758156
29 G>S No ClinGen
gnomAD
CA218581759
rs768639141
30 A>S No ClinGen
Ensembl
CA379501021
rs1405322703
33 M>V No ClinGen
gnomAD
rs200846527
CA218581763
35 C>S No ClinGen
TOPMed
CA218581691
rs977014589
38 S>M No ClinGen
Ensembl
CA5911178
rs756599511
39 I>M No ClinGen
ExAC
gnomAD
TCGA novel 41 M>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA379501116
rs1221206806
41 M>K No ClinGen
gnomAD
CA5911181
rs753917384
41 M>V No ClinGen
ExAC
TOPMed
gnomAD
CA5911168
rs761824195
42 K>P No ClinGen
ExAC
gnomAD
CA379501584
rs1315471901
46 D>H No ClinGen
gnomAD
rs537487381
CA5911173
47 E>N No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA218581748
rs772645002
48 L>A No ClinGen
TOPMed
gnomAD
CA218582894
rs750672775
49 A>D No ClinGen
ExAC
gnomAD
CA5911206
rs750672775
49 A>V No ClinGen
ExAC
gnomAD
CA379500886
rs1279545924
50 L>D No ClinGen
TOPMed
rs144507081
CA218581751
50 L>S No ClinGen
ESP
rs758645316
CA5911207
51 V>I No ClinGen
ExAC
TOPMed
gnomAD
CA5911208
rs780360946
53 V>G No ClinGen
ExAC
gnomAD
rs777884699
CA379501878
56 D>E No ClinGen
ExAC
TOPMed
gnomAD
rs776016684
CA218581757
57 K>A No ClinGen
gnomAD
CA5911214
rs773897712
62 M>I No ClinGen
ExAC
gnomAD
rs1365649442
CA379502133
63 M>I No ClinGen
gnomAD
rs745571742
CA5911215
63 M>L No ClinGen
ExAC
gnomAD
CA379502123
rs745571742
63 M>V No ClinGen
ExAC
gnomAD
rs1398497148
CA379502144
64 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs753250935
CA5911177
65 L>T No ClinGen
ExAC
gnomAD
CA218582924
rs886759716
66 Q>H No ClinGen
Ensembl
TCGA novel 68 G>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5911180
rs777893906
69 S>F No ClinGen
ExAC
TOPMed
gnomAD
CA5911216
rs202095684
69 S>R No ClinGen
ExAC
gnomAD
CA379501118
rs1221206806
70 L>T No ClinGen
gnomAD
rs757310036
CA5911203
73 R>F No ClinGen
ExAC
gnomAD
rs191747797
CA5911217
73 R>G No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1345447577
CA379502518
76 K>E No ClinGen
gnomAD
rs1426332295
CA379503092
83 Y>C No ClinGen
gnomAD
rs200075826
CA218582902
83 Y>M No ClinGen
ExAC
TOPMed
gnomAD
rs1176413079
CA379503114
86 T>I No ClinGen
gnomAD
CA379503122
rs1426305418
88 N>D No ClinGen
gnomAD
rs1340575123
CA379503134
89 S>Y No ClinGen
TOPMed
CA5911257
rs200332813
90 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs201250409
CA218583449
91 L>P No ClinGen
1000Genomes
CA5911258
rs748572565
93 I>F No ClinGen
ExAC
gnomAD
CA218583454
rs778106857
94 I>V No ClinGen
Ensembl
CA379502222
rs1419112895
95 T>* No ClinGen
TOPMed
rs201530363
RCV000994580
CA5911259
95 T>M No ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA218582925
rs202095684
98 A>R No ClinGen
ExAC
gnomAD
TCGA novel 98 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs763532603
CA5911261
99 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1018955701
CA218583460
99 R>H No ClinGen
TOPMed
gnomAD
TCGA novel 99 R>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs764398695
CA5911219
105 S>R No ClinGen
ExAC
gnomAD
CA379503234
rs1480367078
105 S>R No ClinGen
TOPMed
CA379503239
rs1221880983
106 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs145343940
CA5911266
110 V>I No ClinGen
ESP
ExAC
rs199521486
CA5911267
112 R>C No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs771653478
CA379503342
112 R>H No ClinGen
gnomAD
rs771653478
CA218583506
112 R>P No ClinGen
gnomAD
CA379503091
rs1426332295
112 R>S No ClinGen
gnomAD
rs913688115
CA218583448
113 N>D No ClinGen
TOPMed
TCGA novel 114 V>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 120 I>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA379503459
rs1346826614
120 I>V No ClinGen
TOPMed
CA218583520
rs746460566
121 I>V Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA5911273
rs765937866
124 V>A No ClinGen
ExAC
TOPMed
gnomAD
CA379503167
rs201530363
124 V>K No ClinGen
ExAC
TOPMed
gnomAD
CA218583533
rs575345523
125 V>L No ClinGen
Ensembl
rs201958008
CA218583539
127 Y>* No ClinGen
ExAC
gnomAD
CA379503610
rs1404465820
128 S>R No ClinGen
gnomAD
rs754439498
CA5911276
129 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs754439498
CA5911275
129 P>R No ClinGen
ExAC
TOPMed
gnomAD
rs774569446
CA5911263
134 L>G No ClinGen
ExAC
gnomAD
COSM1213236
CA379503240
rs1283076524
COSM1213237
135 I>H large_intestine [Cosmic] No ClinGen
cosmic curated
gnomAD
TCGA novel 139 P>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1351208986
CA379503863
140 V>M No ClinGen
gnomAD
CA218583484
rs745522152
140 V>R No ClinGen
Ensembl
CA379504641
rs1272985965
141 D>Y No ClinGen
gnomAD
CA379504659
rs1456883968
142 I>V No ClinGen
TOPMed
rs777419564
CA5911300
143 L>F No ClinGen
ExAC
gnomAD
CA379504702
rs1200950693
145 Y>N No ClinGen
gnomAD
rs200268273
COSM1139725
CA379504730
COSM542008
146 V>L lung [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA5911302
rs200268273
146 V>M No ClinGen
ExAC
TOPMed
gnomAD
rs145506651
CA5911304
149 K>E No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1480859570
CA379504791
149 K>N No ClinGen
TOPMed
rs1167236350
CA379504854
152 G>A No ClinGen
gnomAD
rs1420549816
CA379503494
152 G>D No ClinGen
gnomAD
rs1167236350
CA379504840
152 G>D No ClinGen
gnomAD
CA218584551
rs138120080
152 G>R No ClinGen
ESP
TOPMed
gnomAD
rs772238965
CA5911305
154 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs149790112
CA218583537
156 N>C No ClinGen
ESP
TOPMed
CA379504969
rs1488155815
157 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs368815124
CA5911307
157 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs368815124
CA5911306
157 R>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA5911308
rs768761936
159 I>T No ClinGen
ExAC
gnomAD
CA379505063
rs1396237391
161 S>G No ClinGen
gnomAD
rs4687
CA218584567
161 S>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs762771019
CA5911310
162 G>S No ClinGen
ExAC
TOPMed
gnomAD
CA5911279
COSM1507420
COSM1507421
rs777988373
166 D>* lung [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs1278078759
CA379505158
166 D>Y No ClinGen
gnomAD
TCGA novel 168 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA5911313
rs201372985
169 R>* No ClinGen
ExAC
TOPMed
gnomAD
rs1461200780
CA379505213
169 R>Q No ClinGen
gnomAD
rs767123470
CA5911314
170 F>Y No ClinGen
ExAC
gnomAD
CA5911315
rs752156024
171 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA5911316
rs760172008
171 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1385447560
CA379505314
174 M>L No ClinGen
TOPMed
rs1424164242
CA379505360
175 G>W No ClinGen
gnomAD
rs145506651
CA218584546
178 L>* No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA5911319
rs757736035
179 G>R No ClinGen
ExAC
gnomAD
CA5911322
rs758823920
182 P>L No ClinGen
ExAC
gnomAD
rs200566403
CA218584603
183 L>S No ClinGen
TOPMed
rs199659698
CA218584599
183 L>V No ClinGen
TOPMed
CA379504914
rs1466951779
184 S>R No ClinGen
gnomAD
rs148186234
CA5911323
186 H>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
gnomAD
RCV000675424
CA5911326
rs201252408
190 L>F No ClinGen
ClinVar
ExAC
dbSNP
gnomAD
TCGA novel 191 G>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 192 E>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA379505209
rs1200853938
197 S>V No ClinGen
gnomAD
rs1337279390
CA379506271
198 V>E No ClinGen
gnomAD
rs1050130076
CA218585004
201 W>C No ClinGen
TOPMed
gnomAD
CA379505353
rs1367582685
203 G>I No ClinGen
TOPMed
rs370781767
CA5911347
204 M>V No ClinGen
ESP
ExAC
CA379506532
rs1219647514
205 N>I No ClinGen
gnomAD
CA379506562
rs1212540504
207 A>T No ClinGen
TOPMed
CA379506647
rs1267663373
210 S>P No ClinGen
gnomAD
rs1488775489
CA379506658
211 L>V No ClinGen
gnomAD
rs1382366706
CA379505743
215 H>Y No ClinGen
gnomAD
CA5911349
rs1554961421
216 P>L No ClinGen
Ensembl
rs1470450944
CA379505864
218 L>F No ClinGen
TOPMed
VAR_004180
CA5911352
rs748436361
222 K>E No ClinGen
UniProt
ExAC
dbSNP
gnomAD
rs190552648
CA5911327
222 K>Y No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs777916242
CA5911355
225 E>K No ClinGen
ExAC
RCV000722494
rs1295332354
226 Q>* No ClinVar
dbSNP
rs745669796
CA5911356
226 Q>H No ClinGen
ExAC
gnomAD
rs780459495
CA5911345
229 E>A No ClinGen
ExAC
gnomAD
CA379506452
rs1287059546
232 K>R No ClinGen
TOPMed
gnomAD
CA379506484
rs1220393077
233 Q>I No ClinGen
gnomAD
rs150740870
CA5911358
235 V>A No ClinGen
ESP
ExAC
gnomAD
rs1446574201
CA379507166
235 V>I No ClinGen
gnomAD
rs760638041
CA5911360
237 S>C No ClinGen
ExAC
rs749493960
CA5911378
238 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA379506661
rs1277705661
240 E>R No ClinGen
TOPMed
rs1248148905
CA379506742
242 I>I No ClinGen
gnomAD
rs1349610606
CA379507642
242 I>L No ClinGen
TOPMed
rs1304107826
CA379507685
244 L>F No ClinGen
TOPMed
rs1218949575
CA379507834
252 I>V No ClinGen
gnomAD
CA379507003
rs1349748996
255 S>E No ClinGen
gnomAD
TCGA novel 256 V>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1304025194
CA379507138
262 S>H No ClinGen
TOPMed
CA5911387
rs772791680
264 M>I No ClinGen
ExAC
TOPMed
gnomAD
rs1184289543
CA379508106
266 N>H No ClinGen
TOPMed
gnomAD
rs1303748888
CA379508149
269 R>Q No ClinGen
TOPMed
gnomAD
CA218585759
rs559447427
269 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs759838023
CA5911391
271 H>N No ClinGen
ExAC
gnomAD
CA379508171
rs1437098895
273 V>I No ClinGen
TOPMed
rs1393389316
CA379508181
274 S>F No ClinGen
TOPMed
CA5911392
rs200256380
275 T>I No ClinGen
ExAC
TOPMed
gnomAD
CA5911394
rs756225293
276 M>T No ClinGen
ExAC
gnomAD
CA5911381
rs746981573
277 I>A No ClinGen
ExAC
gnomAD
rs1244071770
CA379508208
278 K>T No ClinGen
TOPMed
CA5911429
rs761740106
279 G>A No ClinGen
ExAC
CA379508580
rs1176976315
280 L>F No ClinGen
TOPMed
gnomAD
rs776649952
CA5911383
280 L>T No ClinGen
ExAC
TOPMed
gnomAD
CA379508582
rs1176976315
280 L>V No ClinGen
TOPMed
gnomAD
rs199859192
CA5911431
282 G>R No ClinGen
ExAC
TOPMed
gnomAD
rs1160537812
CA379508618
282 G>V No ClinGen
gnomAD
rs147520495
CA5911432
285 D>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA379507938
rs1208949691
287 V>N No ClinGen
TOPMed
gnomAD
TCGA novel 291 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1351386042
CA379508755
293 C>G No ClinGen
gnomAD
rs1257600663
CA379508792
296 G>E No ClinGen
TOPMed
CA5911388
rs762657047
296 G>F No ClinGen
ExAC
gnomAD
rs766720385
CA5911389
297 Q>K No ClinGen
ExAC
TOPMed
gnomAD
CA218585763
rs371400978
299 G>L No ClinGen
ESP
TCGA novel 301 S>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs777517739
CA5911436
303 L>F No ClinGen
ExAC
gnomAD
TCGA novel 304 V>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1190678979
CA379508184
304 V>A No ClinGen
TOPMed
CA218586521
rs753349051
306 V>E No ClinGen
TOPMed
gnomAD
rs199859192
CA379508614
311 E>R No ClinGen
ExAC
TOPMed
gnomAD
VAR_004181
rs200093825
CA5911440
315 R>C No ClinGen
UniProt
ExAC
TOPMed
dbSNP
gnomAD
CA5911442
rs775823378
317 K>R No ClinGen
ExAC
gnomAD
rs752750333
CA5911434
318 K>F No ClinGen
ExAC
gnomAD
TCGA novel 320 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA218586562
rs200908475
321 D>G No ClinGen
Ensembl
rs200019907
CA5911444
321 D>N No ClinGen
ExAC
gnomAD
rs761982670
CA5911446
322 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs776953904
CA5911445
322 T>P No ClinGen
ExAC
gnomAD
CA379509249
rs1375711742
325 G>R No ClinGen
TOPMed
CA218586574
rs201842179
325 G>V No ClinGen
Ensembl
CA218586511
rs201721233
327 Q>H No ClinGen
Ensembl
rs763264028
CA5911450
331 Q>* No ClinGen
ExAC
gnomAD
rs748856517
CA5911437
333 F>M No ClinGen
ExAC

1 associated diseases with P00338

[MIM: 612933]: Glycogen storage disease 11 (GSD11)

A metabolic disorder that results in exertional myoglobinuria, pain, cramps and easy fatigue. {ECO:0000269|PubMed:2334430}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • A metabolic disorder that results in exertional myoglobinuria, pain, cramps and easy fatigue. {ECO:0000269|PubMed:2334430}. Note=The disease is caused by variants affecting the gene represented in this entry.

3 regional properties for P00338

Type Name Position InterPro Accession
domain Lactate/malate dehydrogenase, N-terminal 22 - 160 IPR001236
active_site L-lactate dehydrogenase, active site 190 - 196 IPR018177
domain Lactate/malate dehydrogenase, C-terminal 164 - 324 IPR022383

Functions

Description
EC Number 1.1.1.27 With NAD(+) or NADP(+) as acceptor
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

5 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
extracellular exosome A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
oxidoreductase complex Any protein complex that possesses oxidoreductase activity.

3 GO annotations of molecular function

Name Definition
cadherin binding Binding to cadherin, a type I membrane protein involved in cell adhesion.
identical protein binding Binding to an identical protein or proteins.
L-lactate dehydrogenase activity Catalysis of the reaction: (S)-lactate + NAD+ = pyruvate + NADH + H+.

4 GO annotations of biological process

Name Definition
glycolytic process The chemical reactions and pathways resulting in the breakdown of a carbohydrate into pyruvate, with the concomitant production of a small amount of ATP and the reduction of NAD(P) to NAD(P)H. Glycolysis begins with the metabolism of a carbohydrate to generate products that can enter the pathway and ends with the production of pyruvate. Pyruvate may be converted to acetyl-coenzyme A, ethanol, lactate, or other small molecules.
lactate metabolic process The chemical reactions and pathways involving lactate, the anion of lactic acid.
pyruvate metabolic process The chemical reactions and pathways involving pyruvate, 2-oxopropanoate.
substantia nigra development The progression of the substantia nigra over time from its initial formation until its mature state. The substantia nigra is the layer of gray substance that separates the posterior parts of the cerebral peduncles (tegmentum mesencephali) from the anterior parts; it normally includes a posterior compact part with many pigmented cells (pars compacta) and an anterior reticular part whose cells contain little pigment (pars reticularis).

11 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q5E9B1 LDHB L-lactate dehydrogenase B chain Bos taurus (Bovine) PR
P19858 LDHA L-lactate dehydrogenase A chain Bos taurus (Bovine) PR
Q5R1W9 LDHA L-lactate dehydrogenase A chain Pan troglodytes (Chimpanzee) PR
P07864 LDHC L-lactate dehydrogenase C chain Homo sapiens (Human) PR
P07195 LDHB L-lactate dehydrogenase B chain Homo sapiens (Human) PR
P16125 Ldhb L-lactate dehydrogenase B chain Mus musculus (Mouse) PR
P06151 Ldha L-lactate dehydrogenase A chain Mus musculus (Mouse) PR
P00339 LDHA L-lactate dehydrogenase A chain Sus scrofa (Pig) PR
P04642 Ldha L-lactate dehydrogenase A chain Rattus norvegicus (Rat) PR
Q66KB7 uevld Ubiquitin-conjugating enzyme E2 variant 3 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
Q6DBY5 uevld Ubiquitin-conjugating enzyme E2 variant 3 Danio rerio (Zebrafish) (Brachydanio rerio) PR
10 20 30 40 50 60
MATLKDQLIY NLLKEEQTPQ NKITVVGVGA VGMACAISIL MKDLADELAL VDVIEDKLKG
70 80 90 100 110 120
EMMDLQHGSL FLRTPKIVSG KDYNVTANSK LVIITAGARQ QEGESRLNLV QRNVNIFKFI
130 140 150 160 170 180
IPNVVKYSPN CKLLIVSNPV DILTYVAWKI SGFPKNRVIG SGCNLDSARF RYLMGERLGV
190 200 210 220 230 240
HPLSCHGWVL GEHGDSSVPV WSGMNVAGVS LKTLHPDLGT DKDKEQWKEV HKQVVESAYE
250 260 270 280 290 300
VIKLKGYTSW AIGLSVADLA ESIMKNLRRV HPVSTMIKGL YGIKDDVFLS VPCILGQNGI
310 320 330
SDLVKVTLTS EEEARLKKSA DTLWGIQKEL QF